Literature DB >> 3128631

Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts.

H Karasuyama1, A Rolink, F Melchers.   

Abstract

Plasmacytoma transformants of the X63-Ag8-653 cell line carrying an expression vector with either IL-2, -3, -4, or -5 cDNA were established that secrete the corresponding ILs at high rates. The four mouse ILs (mILs) were then tested as single ILs and in combinations for their effects on the maturation of resting and proliferation of activated normal mouse splenic B cells. mIL-3 and mIL-4 were inactive in all assays. mIL-2, as well as mIL-5, synergized with Ig-specific antibodies and B cell growth factor alpha (BCGF-alpha) to stimulate successive rounds of B cell division with LPS-activated B cells. This activity as BCGF-beta was effective at concentrations similar to those at which mIL-2 induced proliferation of the CTL-L T cell line, indicating a high-affinity interaction of both mIL-2 and mIL-5 with their corresponding receptors on activated B cells. mIL-5 and maybe IL-2 also induced maturation of resting B cells to Ig-secreting cells without proliferation. This B cell maturation factor (BMF) activity of mIL-5 was as effective as its BCGF-beta activity, while the BMF activity of mIL-2 was at least 10(2)-fold less effective. BMF activity of mIL-2, but not mIL-5, was blocked by anti-Il-2-R antibodies, indicating that mIL-2 and mIL-5 use separate receptors for B cell signaling. mIL-2, as well as mIL-5, furthermore, acted as filler activities when proliferation in the presence of Ig-specific antibodies and BCGF-alpha was measured with as little as 500 B cells. In the case of mIL-5, this was also true for maturation of that few cells. Limiting dilution analyses showed that approximately 1-2% of the resting B cells matured without division, while 30-100-fold fewer cells (0.03-0.06%) proliferated and matured in response to IL-5. A single IL, therefore, is capable of inducing maturation and of stimulating mitotic cell cycle progression of normal B cells.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3128631      PMCID: PMC2188910          DOI: 10.1084/jem.167.4.1377

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Synthesis, surface deposition and secretion of immunoglobulin M in bone marrow-derived lymphocytes before and after mitogenic stimulation.

Authors:  F Melchers; J Andersson
Journal:  Transplant Rev       Date:  1973

2.  Cloning of murine transformed cell lines in suspension culture with efficiencies near 100%.

Authors:  W Lernhardt; J Andersson; A Coutinho; F Melchers
Journal:  Exp Cell Res       Date:  1978-02       Impact factor: 3.905

3.  Separation of cells by velocity sedimentation.

Authors:  R G Miller; R A Phillips
Journal:  J Cell Physiol       Date:  1969-06       Impact factor: 6.384

4.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

5.  Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF).

Authors:  K Nakanishi; M Howard; A Muraguchi; J Farrar; K Takatsu; T Hamaoka; W E Paul
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

6.  T-cell-dependent B-cell stimulation is H-2 restricted and antigen dependent only at the resting B-cell level.

Authors:  J Andersson; M H Schreier; F Melchers
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

7.  Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte.

Authors:  J Andersson; A Coutinho; W Lernhardt; F Melchers
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

8.  Identification and initial characterization of a rat monoclonal antibody reactive with the murine interleukin 2 receptor-ligand complex.

Authors:  T R Malek; R J Robb; E M Shevach
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells.

Authors:  R L Coffman; J Ohara; M W Bond; J Carty; A Zlotnik; W E Paul
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

10.  Complete replacement of serum by albumin, transferrin, and soybean lipid in cultures of lipopolysaccharide-reactive B lymphocytes.

Authors:  N N Iscove; F Melchers
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  14 in total

1.  Targeting of T-B interaction using heteroconjugate antibody.

Authors:  J L Davignon; M Vallin-Davignon; P L Cohen; R A Eisenberg
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

Review 2.  Regulation of IgA synthesis and immune response by T cells and interleukins.

Authors:  J R McGhee; J Mestecky; C O Elson; H Kiyono
Journal:  J Clin Immunol       Date:  1989-05       Impact factor: 8.317

3.  Cytokine-induced differentiation of IgA B cells: studies using an IgA expressing B-cell lymphoma.

Authors:  L Eckmann; E Morzycka-Wroblewska; J R Smith; M F Kagnoff
Journal:  Immunology       Date:  1992-06       Impact factor: 7.397

Review 4.  Exercise and the immune system. Natural killer cells, interleukins and related responses.

Authors:  R J Shephard; S Rhind; P N Shek
Journal:  Sports Med       Date:  1994-11       Impact factor: 11.136

5.  Apoptosis and Bcl-2 expression in cultured murine splenic T cells.

Authors:  H E Broome; C M Dargan; E F Bessent; S Krajewski; J C Reed
Journal:  Immunology       Date:  1995-03       Impact factor: 7.397

6.  The acquisition of cytokine responsiveness by murine B cells: a role for antigen and IL-5 in the induction of IL-2 receptors.

Authors:  J Poudrier; T Owens
Journal:  Immunology       Date:  1994-03       Impact factor: 7.397

7.  Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro.

Authors:  G Palladino; P A Scherle; W Gerhard
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

Review 8.  Interleukin-2 in cancer treatment: disappointing or (still) promising? A review.

Authors:  R A Maas; H F Dullens; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1993       Impact factor: 6.968

9.  Fer kinase is required for sustained p38 kinase activation and maximal chemotaxis of activated mast cells.

Authors:  Andrew W B Craig; Peter A Greer
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

10.  Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells.

Authors:  K W Beagley; J H Eldridge; F Lee; H Kiyono; M P Everson; W J Koopman; T Hirano; T Kishimoto; J R McGhee
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.